| scholarly article | Q13442814 |
| P50 | author | Lyle R. Petersen | Q26689960 |
| P2093 | author name string | Roger S. Nasci | |
| Aaron C. Brault | |||
| P2860 | cites work | Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004 | Q24276215 |
| Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey | Q24570061 | ||
| Virus and antibody dynamics in acute west nile virus infection | Q24570066 | ||
| Long-term prognosis for clinical West Nile virus infection | Q24603453 | ||
| The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response | Q24657806 | ||
| West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario | Q27473563 | ||
| Host heterogeneity dominates West Nile virus transmission | Q27477600 | ||
| Association of West Nile virus illness and urban landscapes in Chicago and Detroit | Q27478173 | ||
| Temperature, Viral Genetics, and the Transmission of West Nile Virus by Culex pipiens Mosquitoes | Q27486375 | ||
| Delinquent Mortgages, Neglected Swimming Pools, and West Nile Virus, California | Q27487777 | ||
| Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man | Q27487937 | ||
| Inter-annual associations between precipitation and human incidence of West Nile virus in the United States | Q39159239 | ||
| Surveillance for human West Nile virus disease - United States, 1999-2008. | Q39886491 | ||
| National and regional associations between human West Nile virus incidence and demographic, landscape, and land use conditions in the coterminous United States | Q40036115 | ||
| Current practices and evaluation of screening solid organ donors for West Nile virus | Q40286544 | ||
| Neuromuscular manifestations of west nile virus infection | Q40291825 | ||
| Completeness of West Nile virus testing in patients with meningitis and encephalitis during an outbreak in Arizona, USA. | Q40304517 | ||
| Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in 2003. | Q40308164 | ||
| Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas | Q40340633 | ||
| Primary causes of death in reported cases of fatal West Nile Fever, United States, 2002-2006. | Q40351958 | ||
| Evaluation of efficacy and human health risk of aerial ultra-low volume applications of pyrethrins and piperonyl butoxide for adult mosquito management in response to West Nile virus activity in Sacramento County, California | Q40361009 | ||
| Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. | Q40377193 | ||
| Persistent neuropsychological impairment associated with West Nile virus infection | Q40387338 | ||
| Prognosis after West Nile virus infection | Q40411672 | ||
| West Nile viremic blood donors and risk factors for subsequent West Nile fever | Q40435427 | ||
| West Nile virus isolates from India: evidence for a distinct genetic lineage. | Q40456848 | ||
| Risk factors for encephalitis and death from West Nile virus infection. | Q40479908 | ||
| Effects of temperature on the transmission of west nile virus by Culex tarsalis (Diptera: Culicidae). | Q40481183 | ||
| Nucleic acid testing for west nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients. | Q40481213 | ||
| West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. | Q40482259 | ||
| Characteristics of the rash associated with West Nile virus fever | Q40498613 | ||
| Human exposure to mosquito-control pesticides--Mississippi, North Carolina, and Virginia, 2002 and 2003. | Q40507102 | ||
| Neurological manifestations of West Nile virus infection. | Q40531877 | ||
| Severe West Nile virus disease in healthy adults | Q40543025 | ||
| Transmission of West Nile Virus through Blood Transfusion in the United States in 2002 | Q40550030 | ||
| West Nile virus infection presenting as cerebellar ataxia and fever: case report | Q40551521 | ||
| Evaluation for West Nile Virus (WNV) RNA in urine of patients within 5 months of WNV infection | Q42978598 | ||
| Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype | Q42994909 | ||
| Transient parkinsonism in West Nile virus encephalitis | Q43046915 | ||
| Community aerial mosquito control and naled exposure. | Q44141100 | ||
| Infectious Disease in a Warming World: How Weather Influenced West Nile Virus in the United States (2001–2005) | Q27489018 | ||
| Progress on the development of therapeutics against West Nile virus | Q27489893 | ||
| Persistent Infection with West Nile Virus Years after Initial Infection | Q27490502 | ||
| Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States | Q27860919 | ||
| Experimental infection of North American birds with the New York 1999 strain of West Nile virus | Q29616255 | ||
| The outbreak of West Nile virus infection in the New York City area in 1999 | Q29618175 | ||
| Effects of temperature on emergence and seasonality of West Nile virus in California | Q30513774 | ||
| West Nile virus infection: a new acute paralytic illness | Q30809985 | ||
| Neurologic manifestations and outcome of West Nile virus infection | Q33967282 | ||
| A seroprevalence study of west nile virus infection in solid organ transplant recipients | Q33982270 | ||
| An investigation of depression and fatigue post West Nile virus infection. | Q34110501 | ||
| Demographic and clinical factors associated with persistent symptoms after West Nile virus infection | Q34240166 | ||
| Intensive early season adulticide applications decrease arbovirus transmission throughout the Coachella Valley, Riverside County, California | Q34298842 | ||
| Clinical characteristics and functional outcomes of West Nile Fever | Q34346420 | ||
| CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. | Q34480246 | ||
| Regional differences in the association between land cover and West Nile virus disease incidence in humans in the United States | Q34531170 | ||
| Long-term clinical and neuropsychological outcomes of West Nile virus infection | Q34557857 | ||
| West Nile Fever Characteristics among Viremic Persons Identified through Blood Donor Screening | Q34623850 | ||
| West nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease | Q34763947 | ||
| Keratinocytes are cell targets of West Nile virus in vivo | Q35076652 | ||
| Mental status after West Nile virus infection | Q35793231 | ||
| West Nile Virus-associated flaccid paralysis outcome | Q35793924 | ||
| Cost-effectiveness of West Nile virus vaccination | Q35793943 | ||
| Calgary experience with West Nile virus neurological syndrome during the late summer of 2003. | Q35805871 | ||
| Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008 | Q35844722 | ||
| West Nile virus-associated flaccid paralysis | Q36021961 | ||
| Medical risk factors for severe West Nile Virus disease, United States, 2008-2010 | Q36080087 | ||
| West Nile virus in the Americas | Q37369061 | ||
| Seroprevalence of West Nile virus infection in solid organ transplant recipients | Q37623960 | ||
| West Nile virus infections | Q37633878 | ||
| West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature | Q37828641 | ||
| Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus | Q37842337 | ||
| Immune responses to West Nile virus infection in the central nervous system | Q38068093 | ||
| West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention. | Q38099682 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| West Nile virus | Q158856 | ||
| P304 | page(s) | 308-15 | |
| P577 | publication date | 2013-07-17 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | West Nile virus: review of the literature | |
| P478 | volume | 310 |
| Q90394321 | A 15 Year Evaluation of West Nile Virus in Wisconsin: Effects on Wildlife and Human Health |
| Q27321020 | A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations |
| Q38922725 | A West Nile virus NS4B-P38G mutant strain induces cell intrinsic innate cytokine responses in human monocytic and macrophage cells |
| Q64251176 | A case of West Nile virus encephalitis accompanied by diabetic ketoacidosis and rhabdomyolysis |
| Q57299898 | A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen |
| Q37717816 | A plant-produced antigen elicits potent immune responses against West Nile virus in mice |
| Q51336614 | A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity. |
| Q35801254 | A positively selected mutation in the WNV 2K peptide confers resistance to superinfection exclusion in vivo |
| Q92375578 | A quantitative comparison of West Nile virus incidence from 2013 to 2018 in Emilia-Romagna, Italy |
| Q37708659 | A review of the epidemiological and clinical aspects of West Nile virus |
| Q41809363 | Activation of intrinsic immune responses and microglial phagocytosis in an ex vivo spinal cord slice culture model of West Nile virus infection |
| Q66679199 | AgBR1 antibodies delay lethal -borne West Nile virus infection in mice |
| Q35864559 | Age-Associated Failure To Adjust Type I IFN Receptor Signaling Thresholds after T Cell Activation |
| Q60193818 | Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus |
| Q38898340 | An ex vivo avian leukocyte culture model for West Nile virus infection |
| Q91129614 | An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults |
| Q33850880 | An outbreak of West Nile Virus infection in the region of Monastir, Tunisia, 2003 |
| Q30145610 | Antiviral activity of nordihydroguaiaretic acid and its derivative tetra-O-methyl nordihydroguaiaretic acid against West Nile virus and Zika virus |
| Q24701804 | Apoptosis, autophagy and unfolded protein response pathways in Arbovirus replication and pathogenesis |
| Q47164657 | Arbovirus Diseases, Southeastern United States. |
| Q28081847 | Arbovirus Infections |
| Q28554638 | Archival Isolates Confirm a Single Topotype of West Nile Virus in Australia |
| Q27468896 | Assessing Interventions to Manage West Nile Virus Using Multi-Criteria Decision Analysis with Risk Scenarios |
| Q61795495 | Astrocytes in Flavivirus Infections |
| Q39055227 | Avian and simian malaria: do they have a cancer connection? |
| Q36270372 | Avian species diversity and transmission of West Nile virus in Atlanta, Georgia |
| Q96034382 | Beyond HIV infection: neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases |
| Q55277816 | Biochemistry and Molecular Biology of Flaviviruses. |
| Q89534373 | Can local risk of West Nile virus infection be predicted from previous cases? A descriptive study in Quebec, 2011-2016 |
| Q38611294 | Characterizing environmental risk factors for West Nile virus in Quebec, Canada, using clinical data in humans and serology in pet dogs. |
| Q27001583 | Climate change impacts on West Nile virus transmission in a global context |
| Q26315343 | Climate change projections of West Nile virus infections in Europe: implications for blood safety practices |
| Q97545604 | Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study |
| Q47613934 | Clinical Features of Acute Flaccid Myelitis Temporally Associated with an Enterovirus D68 Outbreak: Results of a Nationwide Survey of Acute Flaccid Paralysis in Japan, August-December 2015. |
| Q98159494 | Clinical Features of Four West Nile Virus Cases and Its Molecular Characterization from a South Indian Tertiary Care Hospital |
| Q40198217 | Clinical, pathological, and immunohistochemical findings in bald eagles (Haliaeetus leucocephalus) and golden eagles (Aquila chrysaetos) naturally infected with West Nile virus |
| Q36406348 | Co-occurrence of viruses and mosquitoes at the vectors' optimal climate range: An underestimated risk to temperate regions? |
| Q57092690 | Comparative Vector Competence of North American and for African and European Lineage 2 West Nile Viruses |
| Q39416470 | Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections |
| Q37664406 | Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010-2012. |
| Q30148695 | Cost effectiveness of a targeted age-based West Nile virus vaccination program |
| Q92409221 | Culex torrentium: A Potent Vector for the Transmission of West Nile Virus in Central Europe |
| Q64916527 | Culicoides Biting Midges-Underestimated Vectors for Arboviruses of Public Health and Veterinary Importance. |
| Q38203769 | Current developments in understanding of West Nile virus central nervous system disease |
| Q34788758 | Current trends in West Nile virus vaccine development |
| Q40110791 | DNA-launched live-attenuated vaccines for biodefense applications |
| Q29365382 | Decision making in the face of uncertainty: the challenge of emerging infectious diseases |
| Q40750374 | Detection Protocols for West Nile Virus in Mosquitoes, Birds, and Nonhuman Mammals |
| Q37496900 | Determinants of the population growth of the West Nile virus mosquito vector Culex pipiens in a repeatedly affected area in Italy |
| Q38903494 | Determining the rate of underrecognition of West Nile virus neurologic disease in the province of Quebec in 2012. |
| Q26315214 | Development and validation of a climate-based ensemble prediction model for West Nile Virus infection rates in Culex mosquitoes, Suffolk County, New York |
| Q89231771 | Dim light at night: physiological effects and ecological consequences for infectious disease |
| Q35133774 | Dispersal of adult culex mosquitoes in an urban west nile virus hotspot: a mark-capture study incorporating stable isotope enrichment of natural larval habitats |
| Q52691889 | Does intra-individual neurocognitive variability relate to neuroinvasive disease and quality of life in West Nile Virus? |
| Q51230778 | Drought and immunity determine the intensity of West Nile virus epidemics and climate change impacts. |
| Q61864330 | Ebola et autres, ces virus venus d’ailleurs |
| Q92050993 | Ecology of West Nile Virus in the Danube Delta, Romania: Phylogeography, Xenosurveillance and Mosquito Host-Feeding Patterns |
| Q34015866 | Effect of aerial insecticide spraying on West Nile virus disease--north-central Texas, 2012. |
| Q34418533 | Emerging and reemerging neurologic infections |
| Q41928947 | Emerging arboviruses in Quebec, Canada: assessing public health risk by serology in humans, horses and pet dogs. |
| Q38156916 | Emerging arboviruses: Why today? |
| Q37676320 | Ensemble forecast of human West Nile virus cases and mosquito infection rates |
| Q30250251 | Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen. |
| Q59351074 | Evaluation of a new West Nile virus nucleic acid test for screening of blood donations |
| Q64123112 | Evaluation of a novel West Nile virus transmission control strategy that targets Culex tarsalis with endectocide-containing blood meals |
| Q26315207 | Evaluation of the vector competence of a native UK mosquito Ochlerotatus detritus (Aedes detritus) for dengue, chikungunya and West Nile viruses |
| Q94673392 | Evidence of West Nile virus infection in migratory and resident wild birds in west coast of peninsular Malaysia |
| Q90109603 | Evolutionary dynamics of lineage 2 West Nile virus in Europe, 2004-2018: Phylogeny, selection pressure and phylogeography |
| Q64135212 | Exotic Tourist Destinations and Transmission of Infections by Swimming Pools and Hot Springs-A Literature Review |
| Q64124423 | Expanded Molecular Testing on Patients with Suspected West Nile Virus Disease |
| Q36853115 | Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals |
| Q42341093 | Fatal Case of West Nile Neuroinvasive Disease in Bulgaria |
| Q40155194 | Fatal West Nile Virus Encephalitis in a Heart Transplant Recipient |
| Q38615396 | Fc receptors in antibody-dependent enhancement of viral infections |
| Q64359207 | Fever in travellers returning from the tropics |
| Q91913005 | Fever in travellers returning from the tropics |
| Q30612045 | Fever of unknown origin in a patient with confirmed west nile virus meningoencephalitis |
| Q40013701 | Fever, Myositis, and Paralysis: Is This Inflammatory Myopathy or Neuroinvasive Disease? |
| Q56877965 | Flaviviruses and Autophagy |
| Q38216286 | Flaviviruses are neurotropic, but how do they invade the CNS? |
| Q64077430 | Flaviviruses as agents of childhood central nervous system infections in Brazil |
| Q66679961 | Flaviviruses as agents of childhood central nervous system infections in Brazil |
| Q59351642 | From dengue to Zika: the wide spread of mosquito-borne arboviruses |
| Q31154829 | Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus |
| Q37235321 | Genome sequencing of West Nile Virus from human cases in Greece, 2012. |
| Q90700313 | Genotypic and phenotypic characterization of West Nile virus NS5 methyltransferase mutants |
| Q42640648 | Health-related quality of life in persons with West Nile virus infection: a longitudinal cohort study |
| Q31064743 | Heterogeneity of Mosquito (Diptera: Culicidae) Control Community Size, Research Productivity, and Arboviral Diseases Across the United States |
| Q40192393 | High-mobility group box-1, promising serological biomarker for the distinction of human WNV disease severity |
| Q55452170 | Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis. |
| Q37562139 | Identification of genetic variants associated with susceptibility to West Nile virus neuroinvasive disease |
| Q35214362 | Identifying the environmental conditions favouring West Nile Virus outbreaks in Europe |
| Q34593800 | Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71 |
| Q89760990 | Impacts of climate change on the public health of the Mediterranean Basin population - Current situation, projections, preparedness and adaptation |
| Q30811442 | Important vector-borne infectious diseases among humans in Germany. Epidemiological aspects |
| Q66679185 | In vitro and in silico Models to Study Mosquito-Borne Flavivirus Neuropathogenesis, Prevention, and Treatment |
| Q37434923 | Increased pathogenicity of West Nile virus (WNV) by glycosylation of envelope protein and seroprevalence of WNV in wild birds in Far Eastern Russia |
| Q91724777 | Increased risk of endemic mosquito-borne diseases in Canada due to climate change |
| Q38897214 | Infectious encephalitis: Management without etiological diagnosis 48hours after onset. |
| Q66678790 | Introduction and Dispersal of Sindbis Virus from Central Africa to Europe |
| Q35035809 | Isolation of West Nile virus from urine samples of patients with acute infection |
| Q91995070 | Japanese encephalitis vaccine-specific envelope protein E138K mutation does not attenuate virulence of West Nile virus |
| Q37376390 | Large human outbreak of West Nile virus infection in north-eastern Italy in 2012 |
| Q38340175 | Latest developments and challenges in the diagnosis of human West Nile virus infection |
| Q38545145 | Long-term sequelae of West Nile virus-related illness: a systematic review |
| Q64082886 | Long-term surveillance defines spatial and temporal patterns implicating Culex tarsalis as the primary vector of West Nile virus |
| Q35590668 | Meteorological conditions associated with increased incidence of West Nile virus disease in the United States, 2004-2012. |
| Q40537444 | MicroRNA reduction of neuronal West Nile virus replication attenuates and affords a protective immune response in mice |
| Q40055010 | Minocycline has anti-inflammatory effects and reduces cytotoxicity in an ex vivo spinal cord slice culture model of West Nile virus infection |
| Q63739936 | Modeling and Surveillance of Reporting Delays of Mosquitoes and Humans Infected With West Nile Virus and Associations With Accuracy of West Nile Virus Forecasts |
| Q40635006 | Mosquito Capture Rate Using CO2-Baited Traps in Relation to Distance From Water and Height: Implications for Avian Disease Transmission |
| Q50107310 | Mosquito community influences West Nile virus seroprevalence in wild birds: implications for the risk of spillover into human populations |
| Q28595151 | Mosquito-Disseminated Insecticide for Citywide Vector Control and Its Potential to Block Arbovirus Epidemics: Entomological Observations and Modeling Results from Amazonian Brazil |
| Q47556358 | Mosquito-borne arboviruses of African origin: review of key viruses and vectors |
| Q35002164 | Multi-criteria decision analysis as an innovative approach to managing zoonoses: results from a study on Lyme disease in Canada |
| Q48245812 | Myoclonus as a late manifestation of West Nile disease |
| Q90705326 | Neuroinvasive West Nile Virus Post-Heart Transplantation: A Case Report |
| Q38239006 | Neuroinvasive arboviral disease in the United States: 2003 to 2012. |
| Q58554005 | Opsoclonus-Myoclonus Syndrome Associated With West-Nile Virus Infection: Case Report and Review of the Literature |
| Q30235969 | Pathology of infectious diseases: what does the future hold? |
| Q92306208 | Patients with laboratory evidence of West Nile virus disease without reported fever |
| Q59352035 | Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection |
| Q34418510 | Peripheral nervous system manifestations of infectious diseases |
| Q92985403 | Phylogenetic analysis of West Nile virus in Quebec, Canada, 2004-2016: Co-circulation of distinct variants harbouring conserved amino acid motifs in North America |
| Q28082778 | Plant-made vaccines against West Nile virus are potent, safe, and economically feasible |
| Q40423085 | Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine |
| Q90052991 | Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination |
| Q66678715 | Predicting West Nile virus transmission in North American bird communities using phylogenetic mixed effects models and eBird citizen science data |
| Q34208783 | Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus |
| Q92602380 | RIG-I-like receptors direct inflammatory macrophage polarization against West Nile virus infection |
| Q90251299 | Reducing West Nile Virus Risk Through Vector Management |
| Q34281513 | Regional variation of climatic influences on West Nile virus outbreaks in the United States |
| Q34424352 | Regulation of cell survival and death during Flavivirus infections |
| Q95855382 | Retrospective Descriptive Analysis of West Nile Neuroinvasive Disease (WNND) in Northwest Louisiana |
| Q40213996 | Retrospective space-time analysis methods to support West Nile virus surveillance activities |
| Q38241424 | Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis |
| Q34789364 | Role of enhanced vector transmission of a new West Nile virus strain in an outbreak of equine disease in Australia in 2011. |
| Q66678707 | STING is required for host defense against neuropathological West Nile virus infection |
| Q64240321 | Sinus Bradycardia and QT Interval Prolongation in West Nile Virus Encephalitis: A Case Report |
| Q43046594 | Southern California neuroinvasive West Nile virus case series |
| Q37393965 | Spatio-temporal epidemiology of human West Nile virus disease in South Dakota |
| Q48097452 | Splenic macrophages are required for protective innate immunity against West Nile virus |
| Q40201894 | Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants |
| Q40081683 | Supersuppression: Reservoir Competency and Timing of Mosquito Host Shifts Combine to Reduce Spillover of West Nile Virus |
| Q60956147 | Suppression of Type I Interferon Signaling by NS5 |
| Q35754402 | Surveillance Potential of Non-Native Hawaiian Birds for Detection of West Nile Virus |
| Q58122913 | Surveillance and Diagnosis of West Nile Virus in the Face of Flavivirus Cross-Reactivity |
| Q30208892 | Surveillance and Early Warning of West Nile Virus Lineage 2 Using Backyard Chickens and Correlation to Human Neuroinvasive Cases |
| Q59352445 | Surveillance for Flaviviruses Near the Mexico-U.S. Border: Co-circulation of Dengue Virus Serotypes 1, 2, and 3 and West Nile Virus in Tamaulipas, Northern Mexico, 2014-2016 |
| Q33940173 | Survival analysis, long-term outcomes, and percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort |
| Q44169075 | Susceptibility of Culex quinquefasciatus (Diptera: Culicidae) in Southern Louisiana to Larval Insecticides |
| Q34197452 | The Australian Public is Still Vulnerable to Emerging Virulent Strains of West Nile Virus |
| Q90016243 | The Effects of a Systemwide Diagnostic Stewardship Change on West Nile Virus Disease Ordering Practices |
| Q52880885 | The Immune Responses of the Animal Hosts of West Nile Virus: A Comparison of Insects, Birds, and Mammals. |
| Q60031638 | The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions |
| Q58610010 | The Neglect and Fast Spread of Some Arboviruses: A Note for Healthcare Providers in Nigeria |
| Q92188843 | The Prevalence of Antibodies against Sandfly Fever Viruses and West Nile Virus in Cyprus |
| Q37434688 | The changing epidemiology of Kunjin virus in Australia |
| Q37295897 | The complex epidemiological scenario of West Nile virus in Italy |
| Q38157732 | The innate immune playbook for restricting West Nile virus infection |
| Q40100524 | The mechanism by which P250L mutation impairs flavivirus-NS1 dimerization: an investigation based on molecular dynamics simulations. |
| Q35115235 | Towards an early warning system for forecasting human west nile virus incidence |
| Q55032072 | Towards an early warning system for forecasting human west nile virus incidence. |
| Q99544119 | Transmission of West Nile and five other temperate mosquito-borne viruses peaks at temperatures between 23°C and 26°C |
| Q59350492 | Use of Next-Generation Sequencing for Diagnosis of West Nile Virus Infection in Patient Returning to Belgium from Hungary |
| Q51148542 | Use of temperature to improve West Nile virus forecasts. |
| Q27329490 | Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus |
| Q35271021 | Vector borne infections in Italy: results of the integrated surveillance system for West Nile disease in 2013 |
| Q43046671 | Vector competence of European mosquitoes for West Nile virus. |
| Q44170025 | Vector-borne diseases and climate change: a European perspective |
| Q99565737 | Vector-borne diseases in pregnancy |
| Q41935743 | Virulence determinants of West Nile virus: how can these be used for vaccine design? |
| Q35059022 | Virus Variation Resource--recent updates and future directions |
| Q92861309 | WEST NILE VIRUS INFECTION WITH NEUROLOGICAL DISORDERS: A CASE REPORT AND A BRIEF REVIEW OF THE SITUATION IN BULGARIA |
| Q38525003 | West Nile Meningoencephalitis Presenting as Isolated Bulbar Palsy With Hypercapnic Respiratory Failure: Case Report and Literature Review |
| Q36366663 | West Nile Virus Challenge Alters the Transcription Profiles of Innate Immune Genes in Rabbit Peripheral Blood Mononuclear Cells |
| Q38567121 | West Nile Virus Encephalitis 16 Years Later |
| Q64921689 | West Nile Virus Encephalitis in Haematological Setting: Report of Two Cases and a Brief Review of the Literature. |
| Q26700105 | West Nile Virus Encephalitis: The First Human Case Recorded in Brazil |
| Q38733889 | West Nile Virus Infection in Human and Mouse Cornea Tissue |
| Q26766121 | West Nile Virus Infection in the Central Nervous System |
| Q66679530 | West Nile Virus and Usutu Virus Co-Circulation in Europe: Epidemiology and Implications |
| Q64068443 | West Nile Virus infection in a renal transplant recipient resulting in polioencephalomylelitis, quadriplegia, and global brain atrophy |
| Q98290871 | West Nile Virus-Induced Neurologic Sequelae-Relationship to Neurodegenerative Cascades and Dementias |
| Q35725809 | West Nile Virus: High Transmission Rate in North-Western European Mosquitoes Indicates Its Epidemic Potential and Warrants Increased Surveillance |
| Q36071951 | West Nile virus IgM and IgG antibodies three years post- infection. |
| Q55396667 | West Nile virus in Canada: ever-changing, but here to stay. |
| Q38535066 | West Nile virus infection in cats: ABCD guidelines on prevention and management |
| Q38577945 | West Nile virus infection in children |
| Q35229705 | West Nile virus infection incidence based on donated blood samples and neuroinvasive disease reports, Northern Texas, USA, 2012. |
| Q40074520 | West Nile virus meningitis in a patient with human immunodeficiency virus type 1 infection. |
| Q57216436 | West Nile virus transmission and human infection risk in Veneto (Italy): a modelling analysis |
| Q92215826 | West Nile virus vaccines - current situation and future directions |
| Q56773518 | West Nile virus, climate change, and circumpolar vulnerability |
| Q40093112 | West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells. |
| Q38190430 | West nile virus infections in children |
| Q48602616 | What place and what future for the pathology of infectious and tropical diseases in France? |
| Q42198288 | Why infectious diseases |
| Q60031617 | Widespread circulation of West Nile virus, but not Zika virus in southern Iran |
| Q24261255 | Zika Virus |
| Q27010749 | Zika virus: An emergent neuropathological agent |
Search more.